Literature DB >> 17113469

Central nervous system toxicity from cancer therapies.

David Schiff1, Patrick Wen.   

Abstract

The central nervous system (CNS) is an organ with a unique profile of vulnerability to antineoplastic treatments. In many cases, CNS neurotoxicity is the dose-limiting side effect of treatment for systemic and CNS neoplasms. Novel methods of delivering radiation and chemotherapy agents have led to recognition of new forms of CNS neurotoxicity. In this article, the authors review the most important CNS toxicities of cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113469     DOI: 10.1016/j.hoc.2006.09.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

1.  Evaluation of multiple neurotoxic outcomes in cancer chemotherapy.

Authors:  Bernard Weiss
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  Chemobrain: a translational challenge for neurotoxicology.

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2008-04-09       Impact factor: 4.294

3.  Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.

Authors:  Mukaila A Raji; Lynsey P Tamborello; Yong-Fang Kuo; Hyunsu Ju; Jean L Freeman; Dong D Zhang; Sharon H Giordano; James S Goodwin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

4.  Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study.

Authors:  Aradeep Chatterjee; Jaydip Biswas; Ashim Chatterjee; Sudin Bhattacharya; Bishnu Mukhopadhyay; Syamsundar Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-08       Impact factor: 2.629

Review 5.  Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.

Authors:  Duccio Maria Cordelli; Riccardo Masetti; Daniele Zama; Francesco Toni; Ilaria Castelli; Emilia Ricci; Emilio Franzoni; Andrea Pession
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.